Samyang Biopharm USA

Samyang Biopharm USA, a subsidiary of Samyang Biopharmaceuticals Corporation (Korea), specializes in the global development of biologics for oncology and rare diseases. We seek global licensing rights for late preclinical stage antibodies, antibody-drug conjugates, and recombinant proteins in clinical development, with a focus on Phase 1 clinical trials in the United States.